Navigation Links
The future of personalized and targeted cancer therapy
Date:4/5/2013

WASHINGTON, D.C. Harnessing the patient's own immune system to fight cancer through genetic modification of their own cells is rapidly emerging as a promising treatment option. Although these therapies provide great opportunities, they also pose unique challenges as investigators seek to refine the approach and expand the treatment option to more patients. A panel discussion at the AACR Annual Meeting 2013 featuring the University of Pennsylvania physician-scientist leading the research team whose work has spurred worldwide attention to chimeric antigen receptor (CAR) technologies, and a trial participant whose leukemia remains in remission more than two and a half years after being treated with his own engineered cells will explore the future of personalized cellular therapies.

WHERE:

AACR Annual Meeting 2013
Room 150
Walter E. Washington Convention Center
801 Mt Vernon Pl NW
Washington, DC 20001

WHEN:

Sunday, April 7, 2013
1 to 3 PM EDT

WHO:

  • Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania and the director of Translational Research in the Abramson Cancer Center
  • Douglas Olson, PhD, Penn Medicine modified T cell trial participant


'/>"/>

Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-200-2313
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1

Related medicine news :

1. Early Thinking Problems May Signal Future Dementia in Parkinsons Patients
2. Researchers decode biology of blood and iron disorders mapping out novel future therapies
3. Pathologists identify patterns of mutations to help inform design of future trials
4. Quadriga Art Offers New Whitepaper: "The Past is the Past: Propel Your Marketing Strategy into the Future"
5. Vitamin D Levels in Pregnancy May Not Affect Kids Future Bone Health
6. Educator and Introducing Broker FuturesANIMAL Officially Launches
7. Predicting hotspots for future flu outbreaks
8. Engineering the future of health care -- from brain mapping to smarter limb prostheses
9. Heart-Healthy Habits in Childhood May Prevent Future Disease
10. Pessimism about the future may lead to longer, healthier life, research finds
11. New cancer vaccine shows future promise in treating and preventing metastatic cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... presets. Use Pixel Film Studios ’ ProParagraph Fashion Volume 2 for ... so many other applications. Users can pick and choose from hand-crafted trend-setting ...
(Date:2/17/2017)... ... 17, 2017 , ... Wells Pharmacy Network offers physicians WellsPx3, ... and non-controlled substances plus the ability to manage orders on their desktop or ... accept electronic prescriptions, according to the Office of the National Coordinator of Health ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... ... 17, 2017 , ... PrideStaff, a national staffing organization, is ... Staffing Industry Analysts' 2017 "Staffing 100 North America" list. , Now in ... to the staffing industry over the last twelve months. Industry insiders and observers ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... planning assistance to families and business owners in the greater Fort Lauderdale metropolitan ... organization. , For more than 30 years, LifeNet 4 Families has provided ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Research and Markets has announced the ... Technologies" report to their offering. ... Traditional medical devices include ... non-drug coated implantables, large endoscopes, needle based drug delivery, lab ... last two to three decades for the treatment and management ...
(Date:2/16/2017)... 2017 DaVita Inc. (NYSE: DVA ) ... 31, 2016. Net income attributable to DaVita ... was $158 million, or $0.80 per share and $880 million, ... income attributable to DaVita Inc. for the quarter and year ... was $192 million, or $0.98 per share, and $789 million, ...
(Date:2/16/2017)... , Feb. 16, 2017  Aralez Pharmaceuticals Inc. ... specialty pharmaceutical company, today announced that executive management will ... to be held February 22-23, 2017. Adrian Adams ... the Company at 1:35 p.m. local time on Wednesday, ... audio archive for the event may be accessed from ...
Breaking Medicine Technology: